Under the post-Brexit deal, EU products should still be able to travel unhindered from the bloc to Northern Ireland. The “vaccine export transparency mechanism″ will be used at least until the end of March to control shipments to non-EU countries. The “advanced purchasing agreement” with the EU was signed in August, before the Oxford-AstraZeneca vaccine had been properly tested. The European Medicines Agency approved the vaccine on Friday, making it the third authorized for use by EU nations. The U.K. is thought to be paying far more for the vaccine than EU countries.

Source: ABC News January 29, 2021 14:21 UTC